Hyperthermic perfusion with chemotherapy for cancers of the extremities.
D001132:Arm; D002056:Burns / Q000209:etiology; D010478:Chemotherapy, Cancer, Regional Perfusion / Q000009:adverse effects; D003609:Dactinomycin / Q000627:therapeutic use; D004487:Edema / Q000209:etiology; D005266:Femoral Neoplasms / Q000628:therapy; D005534:Foot Diseases / Q000628:therapy; D006394:Hemangiosarcoma / Q000628:therapy; D006456:Hemoglobinuria / Q000209:etiology; D006461:Hemolysis; D006358:Hot Temperature / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007866:Leg; D008545:Melanoma / Q000188:drug therapy / Q000628:therapy*; D008558:Melphalan / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D012509:Sarcoma / Q000188:drug therapy / Q000628:therapy*; D012512:Sarcoma, Ewing / Q000628:therapy; D012514:Sarcoma, Kaposi / Q000628:therapy; D013997:Time Factors
D003609:Dactinomycin; D008558:Melphalan